Molecular Diagnostics Market Research Reports & Industry Analysis
Modern technology, however, is beginning to give new meaning to the term “molecular diagnostics.” These new technologies have massive potential for the typing of diseases (e.g., such as in cancer and viral infections), determination of variations in disease state based on therapeutic administration, and the development of newer and more effective therapeutics. Reports in this category will provide market projections, company analysis and testing product trends for this emerging market. NAT testing, molecular prenatal testing, pharmacogenomics, infectious disease testing, are among the areas within molecular diagnostics.
Molecular Diagnostics Industry Research & Market Reports
-
The World Market for Cancer Diagnostics, 2021
... cancer recurrence. The World Market for Cancer Diagnostics, as well as relevant industry merger data provided by Kalorama Information, provides authoritative and complete analysis of the cancer testing industry, with expert market sizing and opportunity ... Read More
-
The World Market for Molecular Diagnostics Tests, 10th Edition
... indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various ... Read More
-
SARS-CoV-2 COVID Vaccine Market Analysis & Forecast to 2026
... and the vast potential of vaccines that are in clinical trials. Kelly Scientific analysis indicates that the global COVID vaccine market was worth $59 billion in 2021. However, our forecast indicates that an initial drop ... Read More
-
COVID-19 Testing Market Update 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends
... has been changed, perhaps permanently. Hundreds of test products are on the market to detect the virus, both for its presence and immune response. And billions of dollars have been added to the in vitro ... Read More
-
The Worldwide Market for In Vitro Diagnostics, 13th Edition
... COVID Testing – Immunoassays and Molecular Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, PGx, Tissue Typing, Prenatal) Clinical Chemistry and “Core Lab” Markets Point-of-Care Testing (POC) (Professional and Self-Testing) Glucose Testing Substance Abuse ... Read More
-
Molecular Diagnostics Markets in The COVID-19 Era
... growth of the worldwide market for molecular diagnostics in all major segments, and does so in this edition as a pandemic has reached developed markets including the United States. 2020 was set to be a ... Read More
-
Emerging Infectious Disease Diagnostics: Markets and Trends
... preparation for a viral epidemic. He predicted that it would be “microbes, not missiles” that would cause significant harm to humans. Events in recent years have proven him right. Outbreaks of infections such as Zika ... Read More
-
Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
... economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for decades. ... Read More
-
Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas
... the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular ... Read More
-
Molecular Cancer Diagnostics Market
... leukemia and lymphoma. Later, the emergence of user-friendly molecular methods such as PCR has opened up practical applications that helped multiple approaches for cancer diagnosis and treatments. DNA sequencing is increasingly employed in cancer molecular ... Read More
-
The World Molecular Diagnostics Market, 8th Edition
... in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment ... Read More
-
The Market and Potential for Molecular Point of Care Diagnostic Tests
... diagnostics (IVD) market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical ... Read More
-
The Market for Library Preparation and Target Enrichment for Next-Generation Sequencing
... revenues and growth rates for 2017-2022 and NGS sample preparation revenues by geographic region for 2017 (North America, Europe, Asia-Pacific, rest-of-world). As NGS science continues to evolve, the report examines trends in the market, including ... Read More
-
Prenatal and Newborn Genetic Screening and Testing Markets (by Application [Carrier Testing, Prenatal Screening, Newborn Testing, Newborn Screening], by Type [Services, Kits] by Geographic Region)
... While many discoveries have been made about the causes of genetic disorders, there remains much more to learn before many of these discoveries can be used as clinical tests – but progress is also being ... Read More
-
IVD in China
... by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. This report provides the following market data: Market by ... Read More
-
Infectious Disease Diagnostic Testing: World Market Analysis of TB, Flu, HIV, Hepatitis, Strep A, Malaria, HPV, Blood Screening, STDs, ID/AST, HAI, Rapids and Other Test Products
... areas of infectious diseases in 25 countries and regions. Diseases and technology categories segmented and forecasted in this report include: Blood Screening Immunoassay Blood Screening NAT Influenza Tests Strep A Test RSV Testing Malaria Tests ... Read More
-
Global Direct-to-Consumer Genetic Testing
... dollars at the manufacturer level. Major world regions include: USA, Europe, Asia/Pacific, and Rest of World. To illustrate historical trends, global demand is provided for 2015 and 2016. Demand by region is provided for 2017. Read More
-
The Market and Potential for Molecular Point of Care Diagnostic Tests
... (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient ... Read More
-
The Market for Direct-to-Consumer Genetic Health Testing
... 2017-2022; revenues and growth for the U.S. European, Asia Pacific, and rest of world DTC genetic testing market, 2017-2022; genetic testing market drivers and barriers; and global DTC genetic testing market analysis featuring genetic testing ... Read More
-
Inherited Disease and Molecular Diagnostics Bundle 2017
Bundle of report sections including Molecular Assay Procedures Inherited Disease Markets Cancer Markers Read More
-
Expected High Growth Market Segments in Molecular Diagnostic Testing
... Kalorama Information. will exceed the average for revenue growth in molecular IVD, according to a new Kalorama Information report. Average molecular IVD products will see six percent growth, the areas identified will be higher, over ... Read More
-
HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC])
... at manufacturer level) Global HIV Testing Market Share Percent by Test Category, 2017 (%; Lab-based, Molecular, POC) Global HIV Testing Market Share Percent by Test Category, 2022 (%; Lab-based, Molecular, POC) The three categories of ... Read More
-
Selected New Products in IVD
New products in IVD, as launched at major diagnostic conventions. Read More
-
The Market for Inherited Disease Molecular Diagnostic Testing
... as well as determine the risk of disease manifestation or progression. Point mutations in genomic DNA occur when a single nucleotide (A,T,C, or G) sequence is altered. Many SNPs have no effect on cell function, ... Read More
-
The Top 25 IVD Companies: Revenue Performance, Products, Strategies, Market Activities
... the most recent trends and developments. Companies included are: Alere Inc. Arkray Beckman Coulter / Danaher Becton Dickinson Bio-Rad Laboratories bioMérieux Cepheid / Danaher Danaher Corp. (including Radiometer A/S) Grifols Hologic Illumina Instrumentation Laboratory / ... Read More
Research Assistance
